换一批
换一批
作者：
A,Younes [1]
;
P,Hilden [2]
;
B,Coiffier [3]
;
A,Hagenbeek [4]
;
G,Salles [3]
;
W,Wilson [5]
;
J F,Seymour [6]
;
K,Kelly [7]
;
J,Gribben [8]
;
M,Pfreunschuh [9]
;
F,Morschhauser [10]
;
H,Schoder [11]
;
A D,Zelenetz [1]
;
J,Rademaker [11]
;
R,Advani [12]
;
N,Valente [13]
;
C,Fortpied [14]
;
T E,Witzig [15]
;
L H,Sehn [16]
;
A,Engert [17]
;
R I,Fisher [18]
;
P-L,Zinzani [19]
;
M,Federico [20]
;
M,Hutchings [21]
;
C,Bollard [22]
;
M,Trneny [23]
;
Y A,Elsayed [24]
;
K,Tobinai [25]
;
J S,Abramson [26]
;
N,Fowler [27]
;
A,Goy [28]
;
M,Smith [29]
;
S,Ansell [15]
;
J,Kuruvilla [30]
;
M,Dreyling [31]
;
C,Thieblemont [32]
;
R F,Little [33]
;
I,Aurer [34]
;
M H J,Van Oers [35]
;
K,Takeshita [36]
;
A,Gopal [37]
;
S,Rule [38]
;
S,de Vos [39]
;
I,Kloos [40]
;
M S,Kaminski [41]
;
M,Meignan [42]
;
L H,Schwartz [43]
;
J P,Leonard [44]
;
S J,Schuster [45]
;
V E,Seshan [2]
作者单位：
Lymphoma Service.
[1]
Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, USA.
[2]
Hematology, Université Lyon-1, Lyon-Sud Charles Mérieux, Lyon, France.
[3]
Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
[4]
Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, USA.
[5]
Peter MacCallum Cancer Centre and University of Melbourne, Australia.
[6]
Pediatrics Department, Roswell-Park Cancer Institute, Buffalo, USA.
[7]
Department of Haemato-Oncology, Barts Cancer Institute, London, UK.
[8]
Department of Internal Medicine, Universität des Saarlandes, Homburg, Germany.
[9]
Department of Hematology, Université de Lille 2, Lille, France.
[10]
Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York.
[11]
Department of Oncology, Stanford University, Stanford.
[12]
Genentech, San Francisco, USA.
[13]
Statistics, EORTC, Brussels, Belgium.
[14]
Mayo Clinic, Rochester, USA.
[15]
British Columbia Cancer Agency, Vancouver, Canada.
[16]
Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
[17]
Fox Chase Cancer Center, Philadelphia, USA.
[18]
Department of Hematology, University of Bologna, Bologna.
[19]
Department of Diagnostic Medicine, University of Modena, Modena, Italy.
[20]
Department of Hematology, University of Copenhagen, Denmark.
[21]
Children's National Health System, Washington, USA.
[22]
Lymphoma and Stem Cell Transplantation Program, Charles University, Prague, Czech Republic.
[23]
Janssen Research & Development, Spring House, USA.
[24]
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
[25]
Massachusetts General Hospital, Center for Lymphoma, Boston.
[26]
U.T. M.D.Anderson Cancer Center, Houston.
[27]
John Theurer Cancer Center, Hackensack University Medical Center, Hackensack.
[28]
Cleveland Clinic, Cleveland, USA.
[29]
Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
[30]
Medicine Clinic III, Ludwig Maximilian University, Munich, Germany.
[31]
Haemato-Oncology, Hôpital Saint Louis, Paris, France.
[32]
Divisions of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, USA.
[33]
Department of Hematology, University Hospital Centre Zagreb, Zagreb, Croatia.
[34]
Academic Medical Center, Amsterdam, The Netherlands.
[35]
Celgene, Summit.
[36]
Fred Hutchinson Cancer Research Center, Seattle, USA.
[37]
Haematology Department, Plymouth University, UK.
[38]
Oncology, UCLA, Los Angeles, USA.
[39]
Servier, Neuilly sur Seine, France.
[40]
University of Michigan Comprehensive Cancer Center, Ann Arbor, USA.
[41]
Nuclear Medicine, Hôpitaux Universitaires Henri Mondor, Créteil, France.
[42]
Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York.
[43]
Weill Cornell Medicine and and New York Presbyterian Hospital, New York.
[44]
University of Pennsylvania School of Medicine, Philadelphia, USA.
[45]
主题词
抗肿瘤药(Antineoplastic Agents);多数赞同(Consensus);造影剂(Contrast Media);疾病恶化(Disease Progression);无病生存(Disease-Free Survival);终点测定(Endpoint Determination);氟脱氧葡萄糖F18(Fluorodeoxyglucose F18);人类(Humans);淋巴瘤, 非霍奇金(Lymphoma, Non-Hodgkin);肿瘤分期(Neoplasm Staging);正电子发射断层显像术(Positron-Emission Tomography);试验预期值(Predictive Value of Tests);时间因素(Time Factors);体层摄影术, X线计算机(Tomography, X-Ray Computed);治疗结果(Treatment Outcome);肿瘤负荷(Tumor Burden)
DOI
10.1093/annonc/mdx097
PMID
28379322
发布时间
2024-03-13
- 浏览66
Annals of oncology
Annals of oncology
1436-1447页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
